Jeeva launches new brand as it pushes AI-ready clinical trials platform

By AI, Created 11:38 AM UTC, May 20, 2026, /AGP/ – Jeeva Clinical Trials unveiled a new logo, visual identity and website at HITLAB’s Innovators Summit in New York City on May 5, 2026. The rebrand spotlights a unified clinical operating system the company says now supports more than 37 studies and 40,000 users and participants.

Why it matters: - Jeeva is trying to position itself as a new kind of clinical research technology company, not just another eClinical vendor. - The rebrand centers on a unified platform that aims to reduce fragmentation across sponsors, CROs, sites and research teams. - Jeeva is also tying its identity to AI-ready clinical operations, which could matter as research organizations look for automation without stitching together multiple point solutions.

What happened: - Jeeva Clinical Trials unveiled a new company logo, visual identity and website at the Healthcare Innovation and Technology Lab’s Innovators Summit in New York City on May 5, 2026. - The launch marks a broader repositioning of Jeeva as an AI-ready clinical operating system. - Jeeva said its unified digital infrastructure is now powering more than 37 clinical studies and serving more than 40,000 users and participants. - The new website is live at JeevaTrials.com.

The details: - Jeeva’s platform is designed around one login, one data model and one workflow layer. - The platform connects eConsent, EDC, ePRO, Telehealth, CTMS and centralized monitoring in a single environment. - Jeeva says the system is FDA-ready and works natively without brittle integrations, data silos or reconciliation issues. - The company says the platform includes trained, ready-to-deploy agentic AI capabilities. - Those AI agents are built for data monitoring, site engagement, patient follow-ups, workflow orchestration and compliance checks. - Jeeva also introduced an industry-first Pricing Calculator that gives sponsors and CROs instant visibility into trial cost on the platform. - The redesigned website highlights the platform’s architecture, module suite and agentic AI capabilities. - Clinical organizations can also add Jeeva’s trained AI agents and Clinical Data Management services as optional add-ons. - The new brand identity takes effect immediately, with a phased rollout across digital platforms, marketing materials and partner channels in the coming weeks. - Jeeva is encouraging sponsors, CROs, academic medical centers and research institutions to visit the new site. - Harsha K Rajasimha, CEO and founder of Jeeva, said the company built the platform to reinvent digital infrastructure for clinical research. - Rajasimha said the new brand reflects the company’s AI-ready infrastructure and its push toward AI-powered clinical operations. - Rob Freishtat, CEO of RareLabs, said Jeeva’s unified EDC and clinical workflow approach gave RareLabs a connected system from day one.

Between the lines: - The rebrand signals a shift from product messaging to category-building, with Jeeva arguing that existing clinical research software models no longer fit its platform. - By combining core trial modules, pricing transparency and AI add-ons under one brand, Jeeva is trying to make the platform easier to evaluate for enterprise buyers. - The company is also making a clear bet that AI will be adopted as a workflow layer, not just as a feature bolted onto existing systems.

What’s next: - Jeeva plans a phased rollout of the new identity across all channels in the weeks ahead. - The company is likely to use the new website and pricing tool to drive adoption among sponsors, CROs and research institutions. - Jeeva is also positioning its AI agents and clinical data management services as the next layer of expansion for customers that want more automation without replacing existing processes.

The bottom line: - Jeeva is using its new brand to make a bigger claim: it wants to be seen as the unified, AI-ready operating system for clinical research, not just a software provider.